FDA Inspection 1135809 — Provention Bio
The FDA completed an inspection of Provention Bio on Feb 4, 2021 in Red Bank, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 4, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Red Bank, NJ (United States)
Additional details
Sponsor, Contract Research Organization